“Cord Blood Is My Baby,” Says Dr Eliane Gluckman

Last month CellPlan joined an international community of cord blood charities and storage facilities in celebrating the inaugural World Cord Blood Day. The aim of the day was to raise awareness about the therapeutic properties of cord-blood and to challenge the routine disposal of umbilical cord blood when a baby is born.

One of the highlights of the programme, organised by Save the Cord Foundation and hosted by Charis Ober, was an interview with Dr Eliane Gluckman, the world’s first doctor to perform a cord blood transplant.

 

“Today we are making history,” said Ober as she asked the legendary haematologist to talk about the contribution of cord blood to medical science. “I’m very glad to talk about cord blood,” Dr Gluckman smiled, “it’s my baby.”

 

Dr Gluckman, now Professor Gluckman, made cord blood history when she performed the world’s first umbilical cord blood transplant in 1988. Since that time, cord blood stem cells have been used in over 40,000 procedures and are routinely used to treat over 80 diseases of the blood and immune systems such as leukaemia, neuroblastoma and sickle cell.

 

How did the first cord blood transplant come about?

“We had already shown that cord blood could successfully be used as a source of haematopoietic stem cells,” the parent cells to all other blood cells in the body, said Dr Gluckman. Bone marrow had been used for some time as a source of stem cells but it was difficult to find a match between patient and donor. Dr Gluckman and her colleagues around the world were looking for a new source of stem cells and began to look at the composition of cord blood.

On the other side of the Atlantic, Dr Gluckman’s colleague Hal Broxmeyer and his team were treating a little boy with Fanconi’s anaemia. Matthew Farrow was born with the rare and fatal blood disease and was terribly ill at the time that his mother was expecting his younger sister, Alison. Having heard about the pioneering work in cord blood, Matthew’s parents made the brave decision to store their Alison’s umbilical cord blood and to use the stem cells it contained to treat Matthew – an operation that had never been performed before.

 

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    Twitter
    LinkedIn
    WideCells Group PLC

    More articles like this

    WideCells Group PLC

    Umbilical blood injects new life into 8-month-old baby

    An 8-month-old girl who had severe combined immune deficiency (SCID) underwent a successful hematopoietic stem cell transplant surgery in Shanghai. The stem cell was taken from umbilical cord blood. Widecells Group PLC (LON:WDC) are leading a

    WideCells Group PLC

    Leukaemia: A Guide To The Cancer Of The Blood

    It is not hereditary, and it is not contagious. It is, however, one of the diseases that kills more children than many others. The word ‘leukaemia’ refers to a group of cancers that spread through the

    WideCells Group PLC

    Autism Treated With Stem Cells

    Researchers at Duke University have utilized autologous (the patient’s own) stem cell infusions to promote increased connectivity in the brain that allowed for improved communication and language abilities in children with Autism Spectrum Disorder (ASD). The

    WideCells Group PLC

    Cord blood banking industry expected to grow

    The list of decisions for new parents already seems endless but it continues to grow as new advances in medicine and technology open new doors for healthcare. Many private companies offer services for collecting and storing